´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2023³âµµ Ãß°èÇмú´ëȸ (1ÀÏÂ÷) : 2023-10-20
±³À°ÀÏÀÚ : 2023-10-20
±³À°Àå¼Ò : ´ë±¸ È£ÅÚÀÎÅͺҰí(¸¸Ã̵¿)
±³À°ÁÖÁ¦ : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2023³âµµ Ãß°èÇмú´ëȸ (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
´ã´çÀÚ : ÀÓ´Ù½½
¿¬¶ôó : 02-537-6171
À̸ÞÀÏ : knpa3355@hanmail.net
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 600¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 30 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 160,000¿ø
ºñ°í - »çÀüµî·Ï: Á¤È¸¿ø 120,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ 70,000 / Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 70,000 / ÀϹÝ(Ÿ°ú ¼Ò¼Ó) 140,000 - ÇöÀåµî·Ï: Á¤È¸¿ø 140,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ 90,000 / Á¤½Å°Ç°°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 90,000 / ÀϹÝ(Ÿ°ú ¼Ò¼Ó) 160,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 09:00~09:20 Application of Transcranial direct and alternating current stimulation (tDCS & tACS) on major depressive disorder À̽ÂÈÆ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 09:20~09:40 Electroconvulsive therapy (ECT) in major depression: Oldie but Goodie À±Á¦¿¬(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 09:40~10:00 The potential and challenges of virtual reality as an adjunctive treatment of depression patients ±èÁØÇü(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 10:00~10:20 Neuroendocrinological treatment targets for major depression À±¼¿µ(´ë±¸°¡Å縯ÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 09:00~09:20 Ä¡·áÈ¿°ú¿Í ÀǷẸÇèÀ» °í·ÁÇÑ Á¤½Å°Ç° Áø·á ¹× Æò°¡Àü·« À̺´Ã¶(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 09:20~09:40 Çѱ¹Çü Á¤½Å°Ç° Æò°¡Ã´µµ °³¹ß ¹æÇâ: ÁöÇÊ°Ë»ç Áß½ÉÀ¸·Î Á¤¼öºÀ(°è¿äº´¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 09:40~10:00 Çѱ¹Çü Á¤½Å°Ç° Æò°¡Ã´µµ °³¹ß ¹æÇâ: µðÁöÅÐ Ä¡·á¿¡¼ »ðÀÔµÈ Æò°¡ Áß½ÉÀ¸·Î ±èÀϺó(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 10:00~10:20 Á¤½Å°Ç° Áø·á¿¡¼ µðÁöÅÐÄ¡·á ¹× Æò°¡Àü·« À̰Ǽ®(ÇѾçÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 10:20~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 09:00~09:25 ¾ËÃ÷ÇÏÀ̸Ӻ´ ´ÜÀÏŬ·Ð Ç×ü Ä¡·áÁ¦ ÃֽŠÀÓ»ó °á°ú: Lecanemab, Donanemab ¾öÀ¯Çö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 09:25~09:50 ¾ËÃ÷ÇÏÀ̸Ӻ´ ´ÜÀÏŬ·Ð Ç×ü Ä¡·áÁ¦ È¿°ú °ËÁõÀ» À§ÇÑ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ÀÓ»ó È°¿ë ¼Õ»óÁØ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 09:50~10:15 ¾ËÃ÷ÇÏÀ̸Ӻ´ ´ÜÀÏŬ·Ð Ç×ü ºÎÀÛ¿ëÀÎ Amyloid Related Imaging Abnormality(ARIA)ÀÇ Æò°¡¿Í ´ëó À̹ΰæ(°¡Å縯ÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 10:15~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ Áñ°Å¿îȦ 09:00~09:25 µðÁöÅй̵ð¾î À¯¹ß ¼Ò¾Æû¼Ò³â Æ®¶ó¿ì¸¶¿Í ÇÇÇØÀÚÀÇ ½ÇÁúÀû ´ëó ¼±Á¤¼ö(ÆÑƮüũ Àü¹®¹Ìµð¾î ´º½ºÅé)
±³À°½Ã°£ 10¿ù 20ÀÏ Áñ°Å¿îȦ 09:25~09:50 û¼Ò³âµéÀÇ »çÀ̹ö¹®È Ư¡: ¼ôÈ®Çà, ¼Ò¼È µô·¹¸¶ ±×¸®°í µðÁöÅÐ ÀÎÁöºÎÁ¶È ¼¹Î¼ö(°æÂûÀÎÀç°³¹ß¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ Áñ°Å¿îȦ 09:50~10:15 ¼Ò¾Æû¼Ò³âÀÇ »çÀ̹ö Æø·Â Æ®¶ó¿ì¸¶ Ä¡·á Áö¿ø ¹è½Â¹Î(°¡ÃµÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ Áñ°Å¿îȦ 10:15~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 09:00~09:25 fnirs in child and adolescent psychiatry È«¹ÎÇÏ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 09:25~09:50 Correlation between cerebral hemodynamic functional near-infrared spectroscopy and positron emission tomography for assessing mild cognitive impairment and Alzheimer¡¯s disease ÀÌ¿µ¹Î(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 09:50~10:15 fNIRS in depression and bipolar disorder ÃÖÁ¾°ü(¢ß ¿ÀºñÀÌ·¦)
Åä·Ð 10¿ù 20ÀÏ ÇູÇÑȦ 10:15~10:30 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1,2,3 10:50~11:40 Becoming a psychiatrist ¹Ú¿ëõ(ÇѾçÀÇ´ë ¸í¿¹±³¼ö, ¹Ú¿ëõÁ¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 12:00~12:25 Cultural context of adhd in clinical practice ÀÌö¼ø(â¿ø°æ»óÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 12:25~12:50 ADHD Ä¡·á °ü·Ã ºÎÀÛ¿ëÀÇ °ü¸® È«Áö¼±(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 12:00~12:25 Clinical therapeutic effect of Tdcs ÃÖÁ¤¼®(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 12:25~12:50 Effectiveness and Safety of tDCS for Treating Depression During Pregnancy ÀÌ»ê(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 12:00~12:25 Clinical Outcomes of Anti-depressant Therapy in Korean MDD Patients: Efficacy & Safety Data of Desvenlafaxine ÀÌÁß¼±(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 12:25~12:50 Comprehensive Consideration for Female MDD Patients with Desvenlafaxine ½Åö¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 14:00~14:45 Is psychiatry Alive? ±èº´¼®(RWJ Rutgers University Medical College)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 13:30~13:50 Subclinical anxiety and depression: an overview ¾ÈÁöÇö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 13:50~14:10 Characteristics of subclinical group of mental health Á¶¼ºÁØ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 14:10~14:30 Neurobiological aspects of subclinical anxiety and depression À±Á¦¿¬(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 14:30~14:50 Therapeutic approach about subclinical anxiety and depression in clinical practice ¾È¸íÈñ(¿ï»êÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 14:50~15:00 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 13:30~13:50 ½Å°æ½É¸®°Ë»ç Æǵ¶ÀÇ µðÁöÅи®Á¦ÀÌ¼Ç ±è±â¿õ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 13:50~14:10 °æµµÀÎÁöÀå¾ÖÀÇ µðÁöÅи®Á¦ÀÌ¼Ç ÀÌÁØ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 14:10~14:30 µðÁöÅÐÄ¡·áÁ¦°¡ °®°í ¿Ã º¯Èµé ÀÌÀ¯Áø(À£Æ®¢ß)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 14:30~14:50 °¡»óÇö½Ç Á¤½Å°ú Ä¡·á: ¿ì¿ïÁõ Ä¡·áÀÇ ¹Ì·¡ Àå¼ö¾Æ(¿¬¼¼ÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 14:50~15:00 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ Áñ°Å¿îȦ 13:30~14:20 Á¤½Å°Ç°ÀÇÇаú Àü°øÀÇ ¿¬Â÷º° ¼ö·Ã¸ñÇ¥ ¹× ¼ö·Ã±³°ú°úÁ¤ ±èÅÂÈñ(¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ Áñ°Å¿îȦ 14:20~15:10 Á¤½Å°Ç°ÀÇÇаú ¼ö·Ã±ÔÁ¤ ¹× ¼ö·Ã½ÇŽɻç±âÁØ ¿ÀÈ«¼®(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ Áñ°Å¿îȦ 15:20~16:10 Á¤½Å°Ç°ÀÇÇаú ¼ö·Ã±³À° ¹ßÀüÀ» À§ÇÑ °í½ÃÁ¦µµ ±è¼º¿Ï(°í½ÃÀ§¿øÀå, Àü³²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ Áñ°Å¿îȦ 16:10~17:00 ¿Â¶óÀÎ Àü°øÀÇ ±³À°½Ã½ºÅÛ È°¿ë¾È³» Àü¸í¿í(±¹¸³Áß¾ÓÀÇ·á¿ø)
Åä·Ð 10¿ù 20ÀÏ Áñ°Å¿îȦ 17:00~17:30 ÁúÀÇÀÀ´ä ¹× Åä·Ð ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 13:30~13:50 ¾Æµ¿ ¸¶À½Ã¬±è ¸í»óÀÇ Àû¿ë ÇöȲ ±Ç¿ë½Ç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 13:50~14:10 ¾Æµ¿ ÀÚºñ ¸í»óÀÇ Àû¿ë ÇöȲ ¹®´ö¼ö(Á¦ÁÖÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 14:10~14:30 ¾Æµ¿À» À§ÇÑ ¸í»óÀÇ ÀÓ»óÀû Àû¿ë ½ÇÁ¦ ¹ÚÁؼº(µÎµå¸²Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 14:30~14:50 Áø·á½Ç¿¡¼ ¹è¿öº¸´Â ¸¶À½Ã¬±è ¿¬½À Á¤µ¿¼±(W Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
Åä·Ð 10¿ù 20ÀÏ ÇູÇÑȦ 14:50~15:00 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 15:10~16:00 Proposals to improve treatment outcome of depression in late-life ±èµµ°ü(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 15:10~15:30 Àΰ£°ü°è Á¤½ÅÄ¡·áÀû °üÁ¡¿¡¼ º» Ä¡·áÀÚÀÇ ¿äÀÎ ¼Õ»ó¿ø(¼¿ï Àΰ£°ü°èÁ¤½ÅºÐ¼®È¸,¿¬¼¼ ¼ÕÁ¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 15:30~15:50 Áöµµ°¨µ¶À» ÅëÇÑ ¿ªÀüÀÌÀÇ ÀÌÇØ ±è°æ³ª(µ¿½ÉÁ¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 15:50~16:10 ºÐ¼®½É¸®ÇÐÀÇ ÀÔÀå¿¡¼ ¹Ù¶óº», ¼º°øÀû Á¤½ÅÄ¡·á¸¦ À§ÇÑ Ä¡·áÀÚ ¿äÀÎ ¹é±âÈ«(¿ï»ê±âµ¶º´¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 16:10~16:30 Ä¡À¯ÀÎÀڷμÀÇ Ä¡·áÀÚÀÇ ÀÎ°Ý ¿ìÁ¤¹Î(°æºÏÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 16:30~16:40 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 15:10~15:30 ¼¼·ÃµÇ°Ô °ÅÀýÇϱâ (ºÎÁ¦ : Á÷Àå¿¡¼ ¼± Àß ±ß±â) ÀÌÇö¿í(ÀÌÇö¿í Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 15:30~15:50 ÀλýÀÇ °¥¸²±æ¿¡¼ Çö¸íÇÑ °áÁ¤Çϱâ(ºÎÁ¦: °áÁ¤À» µ½´Â ÀÎÁöÇൿġ·á ±â¹ý) ¼ÛÇýÇö(µÎµå¸²Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 15:50~16:10 °íÄ¡°í ½ÍÀº ½À°ü¡¦ ¾î¶»°Ô ¹Ù²ãº¼±î? ±èµµÈÆ(±èµµÈÆ Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 16:10~16:30 ŸÀÎÀÇ ½Ã¼±¿¡ Áö³ªÄ¡°Ô ¹Î°¨ÇÑ È¯ÀÚ¸¦ ¾î¶»°Ô µµ¿ÍÁÙ±î ÀÓµ¿±Õ(±èÆ÷´ÙÀºº´¿ø)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 16:30~16:40 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 15:10~15:35 ±Þ¼º±â Á¤½Å°ú ȯÀÚÀÇ ÈïºÐ¿¡ ´ëÇÑ ½É¸®ÇÐÀû ÀÌÇØ¿Í È¯°æ°ú ´ëȸ¦ ÅëÇÑ ¾ÈÁ¤È °úÁ¤ ÀÌ¿äÇÑ(õÁÖÀǼº¿äÇѺ´¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 15:35~16:00 ÈïºÐ»óÅÂÀÇ ±Þ¼º±â Á¤½Å°ú ȯÀÚ¿¡ ´ëÇÑ »ý¹°ÇÐÀû ÀÌÇØ¿Í ¾à¹°À» ÅëÇÑ ¾ÈÁ¤È °úÁ¤ Á¶¿ëÇõ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 16:00~16:25 ÈïºÐ»óÅÂÀÇ ±Þ¼º±â Á¤½Å°ú ȯÀÚ¿¡ ´ëÇÑ ½Åü±â¼úÀ» ÅëÇÑ ¾ÈÁ¤È °úÁ¤(°ÀÇ ¹× ±â¼ú½Ã¿¬) Á¶¹Ì¾Æ, ±è¿ë°©(õÁÖÀǼº¿äÇѺ´¿ø, Àü Àü¶ó³²µµ °æÂûû / Çö űǵµ °üÀå)
Åä·Ð 10¿ù 20ÀÏ ÇູÇÑȦ 16:25~16:40 ÁúÀÇ ÀÀ´ä ()
±âŸ 10¿ù 20ÀÏ ÇູÇÑȦ 16:50~17:10 ´ëÇк´¿øÇü Wee ¼¾ÅÍ 10³âÀÇ ¹ßÀÚÃë ¿ø½ÂÈñ(°æºÏÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÇູÇÑȦ 17:10~17:30 Çб³ ÇöÀå¿¡¼ Á¤½Å°Ç°ÀÇÇаú ÀÇ»çÀÇ ¿ªÇÒ ÀÌÈ£ÁØ(°è¸íÀÇ´ë)
±âŸ 10¿ù 20ÀÏ ÇູÇÑȦ 17:30~17:50 º´¿ø Ä¡·á°¡ ÇÊ¿äÇÑ ÀÚÇØ Ã»¼Ò³âÀ» À§ÇÑ º´¿øÇü Wee ¼¾ÅÍÀÇ ¿ªÇÒ ÃÖÅ¿µ(´ë±¸°¡Å縯ÀÇ´ë)
±âŸ 10¿ù 20ÀÏ ÇູÇÑȦ 17:50~18:10 º´¿øÇü Wee ¼¾ÅÍ ¿ªÇÒÀÇ È®Àå: û¼Ò³â »çÀ̹ö Æø·Â ¹× ÀÎÅÍ³Ý µµ¹Ú Ä¡À¯ ¹æ¾È ¼¿Ï¼®(¿µ³²ÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÇູÇÑȦ 18:10~18:20 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 16:50~17:15 °øµ¿Ã¼°¡ °ÞÀº ½É°¢ÇÑ Æø·ÂÀÇ ½ÇÁ¦ °æÇè : À̵ð¿ÀÇÇ¾Æ ³»Àü Dagimalemu Abire(Myngsung Medical School Hospital of Addis Ababa in Ethiopia)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 17:15~17:40 ºÐ¼®½É¸®ÇÐÀû °üÁ¡¿¡¼ ¹Ù¶óº» ¾Ç°ú Æø·Â ±èÁö¿¬(ÁÁÀº¸¶À½Á¤½Å°Ç°ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 17:40~18:05 Æø·Â°ú ¾ÇÀ» ±Øº¹ÇÏ´Â ÃàÁ¦¿Í Ãã : ºÐ¼®½É¸®ÇÐÀû Çؼ®°ú ´ë¾È ±è±âÇö(ÇöÁ¤½Å°ú ÀÇ¿ø)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ2 18:05~18:20 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 16:50~17:10 ºñ¾à¹° Á¤¼ÀÎÁöÇൿ ÅëÇÕÄ¡·á ÀÌÇöÁÖ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 17:10~17:30 »ýÈ°½À°ü°³¼± ÇÁ·Î±×·¥ ÀÌÇѼº(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 17:30~17:50 ºÒ¾È ¹× ¿Ü»ó °ü·Ã Àå¾Ö ´Ü°èº° Ä¡·á ÃÖ¼öÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 17:50~18:10 ¼ö¸é°Ç°ÁõÁø ÇÁ·Î±×·¥ ÀÌÀ¯Áø(¼¿ïÀÇ´ë)
Åä·Ð 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ3 18:10~18:20 ÁúÀÇ ÀÀ´ä ()
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 16:20~16:35 Attentional bias to game-related visual cues and relationships with self-efficacy in Internet gaming disorder: an event-related potential study ÀÌÇöÈ£(»ï¼º¼¿ïº´¿ø Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 16:35~16:50 PTSD ¼Ò¹æ°ü¿¡¼ÀÇ ¿Ü»ó °ü·Ã ´Ü¾î ³ëÃâ¿¡ µû¸¥ ³ú È°¼º À̼±Àç(Áß¾Ó´ëÇб³º´¿ø)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 16:50~17:05 ȸº¹ Æз¯´ÙÀÓ¿¡ ±â¹ÝÇÑ Ä¡·áÄ£ÈÀû ȯ°æÁ¶¼ºÀ» À§ÇÑ ÀαÇÁ᫐ ÁßÀç±â¼ú°³¹ß ¼Ò°³ Á¶¿ëÇõ(¾ÆÁÖ´ëÇб³º´¿ø Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 17:05~17:20 µðÁöÅÐ °Ç°°ü¸® ½Ã½ºÅÛ(Cancer Manager¢ç)ÀÌ À¯¹æ¾Ï ȯÀÚÀÇ ÀÚ±â°ü¸® È¿´É°¨ ¹× ½É¸® ÀûÀÀ¿¡ ¹ÌÄ¡´Â È¿°ú ±è¼¿¬(Á߾Ӵ뺴¿ø Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 17:20~17:35 Enhancing Mental Health Crisis Care in the Korean Healthcare Context: Drawing Insights from UK Precedents on Crisis Team ij·Ñ¸° ¹®(NHS United Kingdom)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 17:35~17:50 Navigating the Complex Landscape of Opioid Use Disorder: Current Trends, Challenges, and Global Perspectives ¸¶¼º¹Î(Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 17:50~18:05 Association between genetic polymorphisms of Wnt signaling pathway genes and schizophrenia in a Korean population À̾ƶó(°æÈñ´ëÇб³º´¿ø Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 10¿ù 20ÀÏ ÄÁº¥¼ÇȦ1 18:05~18:20 Effectiveness and Safety of Digital Therapeutic Application of Sleep-Index Based Treatment for Insomnia (dSIBT-I): A Randomized Double-blind Prospective Study Á¶ÀαÔ(¼¿ï¾Æ»êº´¿ø Á¤½Å°Ç°ÀÇÇаú)